4//SEC Filing
FITZPATRICK LINDA A 4
Accession 0001415889-25-011998
CIK 0001382101other
Filed
May 4, 8:00 PM ET
Accepted
May 5, 5:48 PM ET
Size
21.6 KB
Accession
0001415889-25-011998
Insider Transaction Report
Form 4
FITZPATRICK LINDA A
CHIEF PEOPLE & COMM. OFFICER
Transactions
- Tax Payment
Common Stock
2025-05-01$1.07/sh−13,538$14,486→ 119,744 total - Exercise/Conversion
Common Stock
2025-05-01+9,125→ 104,558 total - Exercise/Conversion
Common Stock
2025-05-01+13,140→ 127,438 total - Exercise/Conversion
Restricted Stock Unit (RSU)
2025-05-01−9,125→ 0 totalExp: 2026-03-04→ Common Stock (9,125 underlying) - Exercise/Conversion
Restricted Stock Unit (RSU)
2025-05-01−13,140→ 14,685 totalExp: 2028-03-01→ Common Stock (13,140 underlying) - Exercise/Conversion
Common Stock
2025-05-01+5,844→ 133,282 total - Exercise/Conversion
Common Stock
2025-05-01+9,740→ 114,298 total - Exercise/Conversion
Restricted Stock Unit (RSU)
2025-05-01−9,740→ 4,010 totalExp: 2027-03-01→ Common Stock (9,740 underlying) - Exercise/Conversion
Restricted Stock Unit (RSU)
2025-05-01−5,844→ 6,531 totalExp: 2028-03-01→ Common Stock (5,844 underlying)
Holdings
- 10,383(indirect: By Trust)
Common Stock
Footnotes (7)
- [F1]Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person.
- [F2]These securities are held of record by Michael A. Fitzpatrick and Linda A. Fitzpatrick, Trustees of the Michael A. & Linda A. Fitzpatrick Family Trust dated 10/13/1997.
- [F3]Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
- [F4]The RSUs vest as to 1/4th of the total shares annually beginning on March 4, 2023, subject to continued service through each vesting date.
- [F5]The reported transaction represents the accelerated vesting of certain of the reporting person's equity awards outstanding under the issuer's 2018 Equity Incentive Plan, in connection with her separation and transition from her position with the issuer.
- [F6]The RSUs vest as to 1/4th of the total shares annually beginning on March 1, 2024, subject to continued service through each vesting date.
- [F7]The RSUs vest as to 1/4th of the total award annually beginning on March 1, 2025, subject to continued service through each vesting date.
Documents
Issuer
SUTRO BIOPHARMA, INC.
CIK 0001382101
Entity typeother
Related Parties
1- filerCIK 0001188953
Filing Metadata
- Form type
- 4
- Filed
- May 4, 8:00 PM ET
- Accepted
- May 5, 5:48 PM ET
- Size
- 21.6 KB